Show
Sort by
-
Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment
-
Pembrolizumab vs docetaxel for previously treated NSCLC (KEYNOTE-010) : archival vs new tumor samples for PD-L1 assessment
-
Unresectable stage III non-small-cell lung cancer : have we made any progress?
-
Maintenance pazopanib versus placebo in non-small cell lung cancer patients non-progressive after first line chemotherapy: a double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)
-
- Journal Article
- A1
- open access
The systematic early integration of palliative care into multidisciplinary oncology care in the hospital setting (IPAC), a randomized controlled trial : the study protocol
-
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
-
- Journal Article
- A1
- open access
Rehabilitation in patients with radically treated respiratory cancer : a randomised controlled trial comparing two training modalities
-
A phase I study of volasertib combined with afatinib, in advanced solid tumors
-
- Journal Article
- A2
- open access
EGFR mutation positive stage IV non small-cell lung cancer: treatment beyond progression
-
The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients